Background
- Curae Health Group (Curae Health or the Company) is a leading dental services provider in Australia, specialising in providing midstream services in connection with custom-made prostheses and dental radiology
- The Company is headquartered in Melbourne, with locations in Sydney and Perth and services a national network of clients, predominantly dental professionals
- The company engaged AE as an independent corporate advisor on its acquisition of OMNI Dental, a Perth-based laboratory business providing proprietary end-to-end digital implant technology
Our role
- Approach agreed target to initiate contact and build rapport
- Facilitate exploratory meetings and discussions to gauge receptiveness to approach and cultural alignment
- Build investment thesis and requisite internal support documents
- Indicative pricing analysis
- Draft and submit proposal / non-binding indicative offer (NBIO)
- Assist in project management of financial, tax, legal, strategic and commercial due diligence
- Consider funding requirements (soft sounding of brokers)
- Draft and submit final offer/ proposal
- Evaluate synergies, risks, issues, operating model and commence integration planning
- Negotiation of Transaction Documents, such as a Shareholders agreement
- Finalise and executive legal agreements, and announce transaction to shareholders
Outcomes
- Curae Health successfully completed the $15.2m acquisition of OMNI Dental in December 2022, satisfied by a combination of upfront cash, deferred consideration and the issue of scrip in Curae Health to OMNI Dental shareholders
- The acquisition will allow Curae Health to expand its product offering to other locations across Australia, including Western Australia, and integrate OMNI Dental’s end-to-end digital implant technology with Curae Health Group’s existing customer base across the Australian eastern seaboard